{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:52:29Z","timestamp":1793962349276,"version":"4.8.0"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009874","name":"Friuli Venezia Giulia Autonomous Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.parkreldis.2026.108302","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:34:21Z","timestamp":1775756061000},"page":"108302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Continuous subcutaneous levodopa infusion in advanced Parkinson's disease patients with subthalamic nucleus deep brain stimulation"],"prefix":"10.1016","volume":"147","author":[{"given":"David","family":"De Monte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4554-8815","authenticated-orcid":false,"given":"Giovanni","family":"Ermanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bernardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Belgrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Janes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Pellitteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Domenico","family":"Scanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Milia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Betto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarosaria","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lettieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2026.108302_bib1","first-page":"131","article-title":"What was first and what is next in selecting device-aided therapy in Parkinson's disease? Balancing evidence and experience","author":"O","year":"2024","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.parkreldis.2026.108302_bib2","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/mdc3.13228","article-title":"Combining device-aided therapies in parkinson's disease: a case series and a literature review","volume":"8","author":"Boura","year":"2021","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.parkreldis.2026.108302_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/mdc3.70557","article-title":"Continuous subcutaneous versus intestinal levodopa infusion for parkinson's disease: a Real-world, monocentric, observational study and critical review","author":"Hartig","year":"2026","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.parkreldis.2026.108302_bib4","article-title":"RAB39B related parkinsonism in an Italian family: a unique use of advanced therapies","author":"Del Regno","year":"2025","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.parkreldis.2026.108302_bib5","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/archneurol.2010.194","article-title":"Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study","volume":"67","author":"Alcalay","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2026.108302_bib6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.parkreldis.2021.01.020","article-title":"Genetic variants in levodopa-induced dyskinesia (LID): a systematic review and meta-analysis","volume":"84","author":"Falla","year":"2021","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2026.108302_bib7","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1002\/mds.20459","article-title":"Pathophysiology of motor fluctuations in Parkinson's disease","volume":"20","author":"Widnell","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2026.108302_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00002826-199619010-00004","article-title":"Apomorphine tolerance in Parkinson's disease: lack of a dose effect","volume":"19","author":"Gancher","year":"1996","journal-title":"Clin. Neuropharmacol."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380202600129X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380202600129X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:43:51Z","timestamp":1780580631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135380202600129X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":8,"alternative-id":["S135380202600129X"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108302","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continuous subcutaneous levodopa infusion in advanced Parkinson's disease patients with subthalamic nucleus deep brain stimulation","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108302","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108302"}}